• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

TLS-CHOP结构的分子变异性对脂肪生成水平无显著影响:14例黏液样/圆形细胞脂肪肉瘤的超微结构与逆转录聚合酶链反应对比分析

Molecular variability of TLS-CHOP structure shows no significant impact on the level of adipogenesis: a comparative ultrastructural and RT-PCR analysis of 14 cases of myxoid/round cell liposarcomas.

作者信息

Huang Hsuan-Ying, Antonescu Cristina R

机构信息

Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA.

出版信息

Ultrastruct Pathol. 2003 Jul-Aug;27(4):217-26. doi: 10.1080/01913120309917.

DOI:10.1080/01913120309917
PMID:12907366
Abstract

A specific TLS-CHOP fusion gene derived from the t(12;16) is present in at least 95% of myxoid/round cell liposarcomas (MLS). Rare cases of MLS show a variant t(12;22) translocation, resulting in EWS-CHOP fusion gene. The CHOP gene encodes a leucine-zipper transcription factor, which is implicated in both oncogenic transformation and inhibition of adipogenesis. To examine whether the molecular variability of TLS-CHOP or EWS-CHOP fusion transcript structure is associated with the degree of inhibition of adipogenesis, a comparative ultrastructural and RT-PCR-based analysis of 14 MLS was performed. The specimens consisted of 9 primary, 2 locally recurrent tumors, and one representative sample each from 3 patients with multifocal soft tissue metastases. Histologically, there were 8 high-grade and 6 low-grade MLS using 5% round cell (RC) component as the cutoff point. By RT-PCR assay there were 13 cases with TLS-CHOP fusion transcripts: 7 cases of type 5-2 (known as type II), 4 cases of type 7-2 (known as type I),1 case of type 8-2 (known as type III), and 1 unique case of type 6-2. The remaining 1 case showed an EWS-CHOP fusion transcript. Ultrastructural examination revealed that tumor cells were composed of a moderate-to-predominant proportion of well-formed lipoblasts in 4 cases, while in 6 cases such lipoblasts were very scant. The remaining 4 tumors were arrested in the stage of transitional cells. The heterogeneity of TLS-CHOP fusion transcript showed no apparent impact on adipogenesis, since both TLS-CHOP type I and II cases could randomly display various levels of lipoblastic differentiation. Furthermore, the 4 cases without definite lipoblasts showed no preference for any specific fusion variants and consisted of one each of TLS-CHOP subtypes. In addition, the fusion transcript variants did not correlate with other ultrastructural features, such as the presence and amount of glycogen, mitochondria, rough endoplasmic reticulum, vimentin-like intermediate filaments, and external lamina. However, there appeared to have a trend suggesting the predilections of glycogen particles and vimentin-like intermediate filaments in primitive mesenchymal cells and/or transitional cells. These findings cannot substantiate the hypothesis that the molecular variability of fusion transcripts has a biological impact on adipogenesis of MLS, and other factors might be implicated in their level of differentiation.

摘要

源自t(12;16)的特定TLS-CHOP融合基因存在于至少95%的黏液样/圆形细胞脂肪肉瘤(MLS)中。罕见的MLS病例显示出变异的t(12;22)易位,产生EWS-CHOP融合基因。CHOP基因编码一种亮氨酸拉链转录因子,其与致癌转化和成脂抑制均有关。为了研究TLS-CHOP或EWS-CHOP融合转录本结构的分子变异性是否与成脂抑制程度相关,对14例MLS进行了基于超微结构和RT-PCR的比较分析。标本包括9例原发性肿瘤、2例局部复发性肿瘤,以及3例多灶性软组织转移患者各1例代表性样本。组织学上,以5%的圆形细胞(RC)成分作为分界点,有8例高级别和6例低级别MLS。通过RT-PCR检测,有13例存在TLS-CHOP融合转录本:7例为5-2型(称为II型),4例为7-2型(称为I型),1例为8-2型(称为III型),以及1例独特的6-2型。其余1例显示EWS-CHOP融合转录本。超微结构检查显示,4例肿瘤细胞由中等至主要比例的成熟脂肪母细胞组成,而6例中此类脂肪母细胞非常稀少。其余4例肿瘤停滞在过渡细胞阶段。TLS-CHOP融合转录本的异质性对成脂没有明显影响,因为TLS-CHOP I型和II型病例均可随机表现出不同程度的脂肪母细胞分化。此外,4例无明确脂肪母细胞的病例对任何特定融合变体均无偏好,且各包含1种TLS-CHOP亚型。此外,融合转录本变体与其他超微结构特征无关,如糖原、线粒体、粗面内质网、波形蛋白样中间丝和外板的存在及数量。然而,似乎有一个趋势表明糖原颗粒和波形蛋白样中间丝在原始间充质细胞和/或过渡细胞中更常见。这些发现无法证实融合转录本的分子变异性对MLS成脂有生物学影响这一假设,其他因素可能与它们的分化水平有关。

相似文献

1
Molecular variability of TLS-CHOP structure shows no significant impact on the level of adipogenesis: a comparative ultrastructural and RT-PCR analysis of 14 cases of myxoid/round cell liposarcomas.TLS-CHOP结构的分子变异性对脂肪生成水平无显著影响:14例黏液样/圆形细胞脂肪肉瘤的超微结构与逆转录聚合酶链反应对比分析
Ultrastruct Pathol. 2003 Jul-Aug;27(4):217-26. doi: 10.1080/01913120309917.
2
Prognostic impact of P53 status, TLS-CHOP fusion transcript structure, and histological grade in myxoid liposarcoma: a molecular and clinicopathologic study of 82 cases.P53状态、TLS-CHOP融合转录本结构及组织学分级对黏液样脂肪肉瘤的预后影响:82例分子及临床病理研究
Clin Cancer Res. 2001 Dec;7(12):3977-87.
3
Detection of TLS/FUS-CHOP fusion transcripts in myxoid and round cell liposarcomas by nested reverse transcription-polymerase chain reaction using archival paraffin-embedded tissues.利用存档石蜡包埋组织通过巢式逆转录聚合酶链反应检测黏液样和圆形细胞脂肪肉瘤中的 TLS/FUS-CHOP 融合转录本
Diagn Mol Pathol. 1998 Apr;7(2):96-101. doi: 10.1097/00019606-199804000-00006.
4
Specificity of TLS-CHOP rearrangement for classic myxoid/round cell liposarcoma: absence in predominantly myxoid well-differentiated liposarcomas.TLS-CHOP重排在经典黏液样/圆形细胞脂肪肉瘤中的特异性:在主要为黏液样高分化脂肪肉瘤中不存在。
J Mol Diagn. 2000 Aug;2(3):132-8. doi: 10.1016/S1525-1578(10)60628-9.
5
Myxoid liposarcoma with adipocytic maturation: detection of TLS/CHOP fusion gene transcript.伴有脂肪细胞成熟的黏液样脂肪肉瘤:TLS/CHOP融合基因转录本的检测
Diagn Mol Pathol. 2004 Jun;13(2):92-6. doi: 10.1097/00019606-200406000-00005.
6
Myxoid liposarcoma confirmed by TLS/FUS-CHOP fusion transcripts.经 TLS/FUS-CHOP 融合转录本证实的黏液样脂肪肉瘤。
Dermatol Surg. 2003 Sep;29(9):980-1. doi: 10.1046/j.1524-4725.2003.29265.x.
7
Chimeric TLS/FUS-CHOP gene expression and the heterogeneity of its junction in human myxoid and round cell liposarcoma.嵌合型 TLS/FUS-CHOP 基因表达及其在人黏液样和圆形细胞脂肪肉瘤中连接区的异质性
Am J Pathol. 1995 Nov;147(5):1221-7.
8
[Detection of FUS-CHOP fusion gene in paraffin-embedded tissues and its clinicopathologic significance for myxoid/round cell liposarcomas].石蜡包埋组织中FUS-CHOP融合基因的检测及其对黏液样/圆形细胞脂肪肉瘤的临床病理意义
Zhonghua Bing Li Xue Za Zhi. 2005 Jan;34(1):28-32.
9
A novel type of EWS-CHOP fusion gene in two cases of myxoid liposarcoma.两例黏液样脂肪肉瘤中的一种新型EWS-CHOP融合基因。
J Mol Diagn. 2002 Aug;4(3):164-71. doi: 10.1016/S1525-1578(10)60698-8.
10
FUS/TLS-CHOP chimeric transcripts in liposarcoma tissues.脂肪肉瘤组织中的FUS/TLS-CHOP嵌合转录本
Jpn J Clin Oncol. 1995 Dec;25(6):234-9.

引用本文的文献

1
FUS::DDIT3 Fusion Protein in the Development of Myxoid Liposarcoma and Possible Implications for Therapy.FUS::DDIT3 融合蛋白在黏液样脂肪肉瘤的发生发展中的作用及其对治疗的可能影响。
Biomolecules. 2024 Oct 14;14(10):1297. doi: 10.3390/biom14101297.
2
Extensive lipoma-like changes of myxoid liposarcoma: morphologic, immunohistochemical, and molecular cytogenetic analyses.黏液样脂肪肉瘤的广泛脂肪瘤样改变:形态学、免疫组织化学及分子细胞遗传学分析
Virchows Arch. 2015 Apr;466(4):453-64. doi: 10.1007/s00428-015-1721-z. Epub 2015 Feb 4.
3
Molecular strategies for detecting chromosomal translocations in soft tissue tumors (review).
检测软组织肿瘤中染色体易位的分子策略(综述)
Int J Mol Med. 2014 Jun;33(6):1379-91. doi: 10.3892/ijmm.2014.1726. Epub 2014 Apr 4.
4
Extensive adipocytic maturation can be seen in myxoid liposarcomas treated with neoadjuvant doxorubicin and ifosfamide and pre-operative radiation therapy.在接受新辅助阿霉素和异环磷酰胺治疗以及术前放射治疗的黏液样脂肪肉瘤中,可以看到广泛的脂肪细胞成熟。
Clin Sarcoma Res. 2012 Dec 29;2(1):25. doi: 10.1186/2045-3329-2-25.
5
Kinome profiling of myxoid liposarcoma reveals NF-kappaB-pathway kinase activity and casein kinase II inhibition as a potential treatment option.黏液样脂肪肉瘤的激酶组分析揭示了 NF-κB 通路激酶活性和酪蛋白激酶 II 抑制作用,这可能是一种潜在的治疗选择。
Mol Cancer. 2010 Sep 23;9:257. doi: 10.1186/1476-4598-9-257.